Your browser doesn't support javascript.
loading
Evaluation of a locked nucleic acid form of antisense oligo targeting HIF-1α in advanced hepatocellular carcinoma.
Wu, Jennifer; Contratto, Merly; Shanbhogue, Krishna P; Manji, Gulam A; O'Neil, Bert H; Noonan, Anne; Tudor, Robert; Lee, Ray.
Afiliación
  • Wu J; Division of Hematology and Oncology, Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016, United States. jennifer.wu@nyumc.org.
  • Contratto M; Division of Hematology and Oncology, Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016, United States.
  • Shanbhogue KP; Department of Radiology at New York University School of Medicine, New York, NY 10016, United States.
  • Manji GA; Division of Hematology and Oncology, Columbia University Medical Center, New York, NY 10032, United States.
  • O'Neil BH; Division of Hematology and Oncology, Indiana University, Indianapolis, IN 46202, United States.
  • Noonan A; Division of Hematology and Oncology, Ohio State University Medical Center, Columbus, OH 43210, United States.
  • Tudor R; Roche Pharmaceutical Company, New York, NY 10016, United States.
  • Lee R; Roche and Teclison Pharmaceutical Company, Montclair, NJ 07042, United States.
World J Clin Oncol ; 10(3): 149-160, 2019 Mar 24.
Article en En | MEDLINE | ID: mdl-30949444
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: World J Clin Oncol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: World J Clin Oncol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos